個人化營養和補充劑市場－全球產業規模、佔有率、趨勢、機會、預測：按成分、劑型、最終用途、地區和競爭對手分類，2021-2031年

全球個人化營養和補充劑市場預計將從 2025 年的 547.2 億美元成長到 2031 年的 1,189.8 億美元，複合年成長率達 13.82%。

該市場專注於提供客製化的飲食建議和配方產品，這些產品經過精心設計，旨在滿足個人獨特的生理和生活方式需求，而這些需求通常透過先進的基因檢測、微生物組檢測或生物標記檢測來確定。推動這一市場擴張的關鍵因素包括全球文明病的日益普遍，以及整個行業向預防醫學的重大轉變。此外，診斷技術的快速發展使得對個人營養需求的評估更加精準，從而推動市場從傳統的大量生產產品模式朝向更高階的模式發展。

市場促進因素

人工智慧 (AI) 和巨量資料在營養診斷領域的融合正在從根本上重塑市場格局。這使得處理複雜的生物資料整合為可能，並推動了精準醫療的發展。與傳統方法不同，人工智慧演算法現在能夠分析大量的微生物組、基因和代謝數據，從而製定高度特異性的膳食干預方案。這正將業界從提供廣泛的建議轉向以生物學為導向的解決方案。這種技術能力正在吸引大量投資，例如，Viome Life Sciences 在 2024 年 9 月成功完成 2,500 萬美元的 D 輪融資，用於推出其診斷部門並擴展其人工智慧驅動的預防性醫療保健技術。這凸顯了先進的數據分析在為更多消費者提供個人化資金籌措所發揮的關鍵作用。同時，穿戴式健康技術和自我監測設備的普及正在推動關鍵數據的收集，提供持續的即時生理回饋，這對於動態個人化至關重要。這些設備監測心率變異性、睡眠品質和活動量等指標，形成回饋迴路，使營養師能夠根據個人的日常表現和恢復狀況調整建議。這一趨勢的商業性成功得益於市場對先進穿戴裝置的強勁需求。 Garmin健身部門的銷售額預計在2024年將達到17.7億美元，年增31%。硬體普及率的激增與消費者對個人化健康解決方案的期望直接契合，而69%的營養補充劑使用者強調個人化攝取方案的重要性，也印證了技術應用與客製化照護之間的緊密聯繫。

市場挑戰

監管的複雜性是全球個人化營養和補充劑市場成長的主要障礙。利用敏感生物資料進行個人化產品開發的公司必須應對一個碎片化的法律環境，該環境的特徵是不同司法管轄區的資料隱私法規各不相同，科學檢驗標準也不一致。這種監管的不一致導致企業需要投入大量資金用於合規，從而推高營運成本，並延緩創新診斷工具在國際市場的推出。此外，缺乏統一的測試方法檢驗框架造成了不確定性，最終損害了消費者的信任。由於缺乏明確的監管標準，潛在用戶難以區分經過科學檢驗的個人化解決方案和通用替代品，導致他們猶豫不決。這種圍繞著行業監管的混亂局面是可以量化的，並且對市場滲透率產生了負面影響。根據消費者保健產品協會 (CHPA) 的數據，到 2025 年，52% 的受訪者錯誤地認為營養補充品類別不受監管，或對其監管狀況不確定。這些統計數據表明，不明確和複雜的監管環境會滋生不信任，並直接阻礙產業將消費者興趣轉化為永續市場成長的能力。

市場趨勢

3D列印技術在定製劑型領域的應用，突破了傳統製造流程的限制，正在改變營養物質的輸送方式。這項創新技術能夠生產“複合藥丸”，將多種成分封裝在不同層中，從而提高生物利用度和患者依從性。與大規模生產的膳食補充劑不同，3D列印技術可以根據生物數據即時調整劑量，從而建立動態供應鏈。專業製造商的發展趨勢清晰地反映了這一領域的快速成長。 Rem3dy Health公司報告稱，過去三年其年均銷售額成長了100.04%，凸顯了個人化生產的趨勢。同時，以女性健康科技主導的個人化荷爾蒙營養療法正在推動人們更好地應對與生殖功能和更年期相關的代謝波動。這一趨勢超越了普通綜合維他命，強調“階段性補充方案”，即根據特定的荷爾蒙變化調整營養攝取。這種針對性的調查方法吸引了大量投資，因為投資者意識到市場對針對特定生物特徵量身定做的解決方案有著強勁的需求。例如，以女性生理需求為優先的創新為驅動力的女性科技市場，在2024年實現了55%的年成長。這種強勁的投資活動象徵著一個日益成熟的生態系統，在這個生態系統中，個人化營養在管理荷爾蒙健康方面發揮著至關重要的作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球個人化營養與補充品市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依成分分類（蛋白質/胺基酸、維生素、礦物質、益生菌、草藥/植物）
  • 劑型（片劑/膠囊、液體、粉末、其他）
  • 按應用場景（超級市場/大賣場、專賣店、零售藥局、網路藥局/電子商務網站）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美個人化營養與補充品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲個人化營養與補充品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區個人化營養及補充品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲個人化營養和補充品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲個人化營養與補充品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球個人化營養與補充品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Amway Corporation
• Superior Supplements Inc
• Metagenics, Inc.
• Nutralliance, Inc.
• Archer Daniels Midland Company
• Viome Life Sciences, Inc.
• DNAFit Life Sciences Ltd
• Abbott Laboratories Inc
• Herbalife International of America, Inc.
• GX Sciences, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Personalized Nutrition And Supplements Market is projected to experience substantial growth, expanding from USD 54.72 Billion in 2025 to USD 118.98 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.82%. This market focuses on delivering customized dietary advice and formulated products, meticulously designed to cater to an individual's distinct biological and lifestyle requirements, often identified through advanced genetic, microbiome, or biomarker testing. Key drivers for this expansion include the rising global incidence of chronic lifestyle diseases and a significant industry-wide pivot towards preventive healthcare. Furthermore, swift progress in diagnostic technologies facilitates highly accurate assessments of individual nutrient needs, thereby fostering the market's evolution beyond conventional, mass-produced offerings.

Market Driver

The market is fundamentally being reshaped by the integration of Artificial Intelligence and big data into nutritional diagnostics, which processes intricate biological datasets to advance precision health. Diverging from conventional approaches, AI algorithms now analyze extensive microbiome, genetic, and metabolic data to formulate highly specific dietary interventions, thereby transitioning the industry from broad advice to biologically targeted solutions. This technological prowess attracts considerable investment, as exemplified by Viome Life Sciences securing $25 million in Series D funding in September 2024 to launch its diagnostic division and expand its AI-driven preventative health technologies, highlighting the crucial role of advanced data analytics in bringing personalized nutrition to a wider consumer base. Simultaneously, the widespread adoption of wearable health technology and self-monitoring devices serves as a key data acquisition engine, supplying continuous, real-time physiological feedback essential for dynamic personalization. These devices monitor metrics like heart rate variability, sleep quality, and activity, establishing a feedback loop that enables nutrition providers to adapt recommendations based on an individual's daily performance and recovery. The commercial success of this trend is underscored by Garmin Ltd.'s 2024 fitness segment revenue growth of 31% year-over-year to $1.77 billion, driven by robust demand for advanced wearables. This surge in hardware adoption aligns directly with consumer expectations for tailored health solutions, with 69% of supplement users emphasizing the importance of personalized regimens, validating the strong connection between technological engagement and customized care.

Market Challenge

Regulatory complexity presents a substantial barrier to the growth of the global personalized nutrition and supplements market. Companies leveraging sensitive biological data for tailored products must navigate a fragmented legal environment, characterized by disparate data privacy regulations and inconsistent scientific validation standards across various jurisdictions. This lack of regulatory harmonization necessitates significant compliance investments, which in turn inflate operational costs and postpone the introduction of innovative diagnostic tools into international markets. Moreover, the absence of a consistent framework for validating testing methods introduces ambiguity, thereby diminishing consumer trust. Without clear regulatory benchmarks, prospective users often find it difficult to differentiate between scientifically validated personalized solutions and generic alternatives, resulting in reluctance to adopt. This confusion surrounding industry oversight is quantifiable and negatively impacts market penetration; in 2025, 52% of voters incorrectly believed the dietary supplement category was unregulated or were uncertain of its regulatory status, according to the Consumer Healthcare Products Association. Such statistics demonstrate how an unclear and intricate regulatory landscape fosters distrust, directly hindering the industry's capacity to translate consumer interest into sustained market expansion.

Market Trends

The adoption of 3D-printing technology for customized dosage forms is transforming nutrient delivery by surmounting conventional manufacturing constraints. This innovation facilitates the creation of "polypills" containing multiple ingredients encapsulated in distinct layers, which enhances bioavailability and patient adherence. In contrast to mass-produced supplements, 3D printing enables real-time dosage adjustments informed by biological data, thereby fostering a dynamic supply chain. The rapid growth of this sector is exemplified by specialized manufacturers, with Rem3dy Health reporting an average annual revenue increase of 100.04% over three years, highlighting the shift towards personalized manufacturing. Concurrently, the emergence of Femtech-driven personalized hormonal nutrition is addressing metabolic fluctuations linked to fertility and menopause. This trend transcends generic multivitamins, favoring phasic supplementation protocols that align nutrient intake with specific hormonal shifts. This targeted methodology is drawing considerable investment, as investors acknowledge the strong demand for biologically specific solutions. The Femtech market, for instance, saw a 55% year-over-year increase in 2024, propelled by innovations that prioritize women's physiological needs. This robust investment activity signifies a maturing ecosystem where personalized nutrition plays a pivotal role in managing hormonal health.

Key Market Players

• Amway Corporation
• Superior Supplements Inc
• Metagenics, Inc.
• Nutralliance, Inc.
• Archer Daniels Midland Company
• Viome Life Sciences, Inc.
• DNAFit Life Sciences Ltd
• Abbott Laboratories Inc
• Herbalife International of America, Inc.
• GX Sciences, LLC

Report Scope

In this report, the Global Personalized Nutrition And Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Personalized Nutrition And Supplements Market, By Ingredient

• Proteins & Amino Acid
• Vitamins
• Minerals
• Probiotics
• Herbal/Botanic

Personalized Nutrition And Supplements Market, By Dosage Form

• Tablets/Capsules
• Liquids
• Powders
• Other

Personalized Nutrition And Supplements Market, By End Use

• Supermarkets/Hypermarkets
• Specialty Stores
• Retail Pharmacies
• Online Pharmacies & E-Commerce Sites

Personalized Nutrition And Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Personalized Nutrition And Supplements Market.

Available Customizations:

Global Personalized Nutrition And Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Personalized Nutrition And Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Ingredient (Proteins & Amino Acid, Vitamins, Minerals, Probiotics, Herbal/Botanic)
  • 5.2.2. By Dosage Form (Tablets/Capsules, Liquids, Powders, Other)
  • 5.2.3. By End Use (Supermarkets/Hypermarkets, Specialty Stores, Retail Pharmacies, Online Pharmacies & E-Commerce Sites)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Personalized Nutrition And Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Ingredient
  • 6.2.2. By Dosage Form
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Personalized Nutrition And Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Ingredient
      • 6.3.1.2.2. By Dosage Form
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Personalized Nutrition And Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Ingredient
      • 6.3.2.2.2. By Dosage Form
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Personalized Nutrition And Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Ingredient
      • 6.3.3.2.2. By Dosage Form
      • 6.3.3.2.3. By End Use

7. Europe Personalized Nutrition And Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Ingredient
  • 7.2.2. By Dosage Form
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Personalized Nutrition And Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Ingredient
      • 7.3.1.2.2. By Dosage Form
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Personalized Nutrition And Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Ingredient
      • 7.3.2.2.2. By Dosage Form
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Personalized Nutrition And Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Ingredient
      • 7.3.3.2.2. By Dosage Form
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Personalized Nutrition And Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Ingredient
      • 7.3.4.2.2. By Dosage Form
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Personalized Nutrition And Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Ingredient
      • 7.3.5.2.2. By Dosage Form
      • 7.3.5.2.3. By End Use

8. Asia Pacific Personalized Nutrition And Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Ingredient
  • 8.2.2. By Dosage Form
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Personalized Nutrition And Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Ingredient
      • 8.3.1.2.2. By Dosage Form
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Personalized Nutrition And Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Ingredient
      • 8.3.2.2.2. By Dosage Form
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Personalized Nutrition And Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Ingredient
      • 8.3.3.2.2. By Dosage Form
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Personalized Nutrition And Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Ingredient
      • 8.3.4.2.2. By Dosage Form
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Personalized Nutrition And Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Ingredient
      • 8.3.5.2.2. By Dosage Form
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Personalized Nutrition And Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Ingredient
  • 9.2.2. By Dosage Form
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Personalized Nutrition And Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Ingredient
      • 9.3.1.2.2. By Dosage Form
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Personalized Nutrition And Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Ingredient
      • 9.3.2.2.2. By Dosage Form
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Personalized Nutrition And Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Ingredient
      • 9.3.3.2.2. By Dosage Form
      • 9.3.3.2.3. By End Use

10. South America Personalized Nutrition And Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Ingredient
  • 10.2.2. By Dosage Form
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Personalized Nutrition And Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Ingredient
      • 10.3.1.2.2. By Dosage Form
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Personalized Nutrition And Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Ingredient
      • 10.3.2.2.2. By Dosage Form
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Personalized Nutrition And Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Ingredient
      • 10.3.3.2.2. By Dosage Form
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Personalized Nutrition And Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Amway Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Superior Supplements Inc
• 15.3. Metagenics, Inc.
• 15.4. Nutralliance, Inc.
• 15.5. Archer Daniels Midland Company
• 15.6. Viome Life Sciences, Inc.
• 15.7. DNAFit Life Sciences Ltd
• 15.8. Abbott Laboratories Inc
• 15.9. Herbalife International of America, Inc.
• 15.10. GX Sciences, LLC

16. Strategic Recommendations

17. About Us & Disclaimer